Contact
searchSearch
HMP Global

Thrombectomy Videos

Dr Mouawad speaks at ISET 2026
ISET 2026
Advancing Thrombectomy and Autologous Blood Reinfusion for Pulmonary Embolism Treatment: Results from the AVENTUS Pivotal Study
04/09/2026
Nicolas J. Mouawad, MD, MPH, MBA
Dr Mouawad discusses the results of the AVENTUS pivotal trial.
Dr Mouawad discusses the results of the AVENTUS pivotal trial.
Dr Mouawad discusses the results...
04/09/2026
Vascular Disease Management
Dr Constantino Pena
AMP 2024
High Limb Salvage Rate and Improved Quality of Life Following Aspiration Thrombectomy With Indigo for Lower-Extremity Acute Limb Ischemia
09/11/2024
Constantino S. Peña, MD, FAHA, FSCCT, FSIR
Watch as Dr. Constantino Peña discusses his AMP presentation on the 12-month results from the STRIDE study.
Watch as Dr. Constantino Peña discusses his AMP presentation on the 12-month results from the STRIDE study.
Watch as Dr. Constantino Peña...
09/11/2024
Vascular Disease Management
Dr Lichtenberg
ISET 2024
Final Subgroup Analysis From the Rotarex Post-Market Study
03/06/2024
Michael Lichtenberg, MD, FESC
Dr. Michael Lichtenberg discusses his presentation on the Rotarex Post-Market Study at ISET 2024.
Dr. Michael Lichtenberg discusses his presentation on the Rotarex Post-Market Study at ISET 2024.
Dr. Michael Lichtenberg...
03/06/2024
Vascular Disease Management
Dr Osman Ahmed
ISET 2024
Management of Acute and Chronic Lower Extremity Venous Obstruction
03/05/2024

Osman Ahmed, MD
UChicago Medicine, Chicago, Illinois

Osman Ahmed, MD UChicago Medicine, Ch...
Watch as Dr. Osman Ahmed discusses his ISET 2024 presentation on acute and chronic lower extremity venous obstruction.
Watch as Dr. Osman Ahmed discusses his ISET 2024 presentation on acute and chronic lower extremity venous obstruction.
Watch as Dr. Osman Ahmed...
03/05/2024
Vascular Disease Management
Dr Lichtenberg
AMP 2023
24-Month Results From the Prospective Multicenter Study of the Rotarex Atherectomy and Thrombectomy Catheter System
12/11/2023
Michael Lichtenberg, MD, FESC
Dr. Michael Lichtenberg discusses his presentation on the latest results from a European trial analyzing the efficacy and safety of the Rotarex device (BD) for patients with femoropopliteal disease.
Dr. Michael Lichtenberg discusses his presentation on the latest results from a European trial analyzing the efficacy and safety of the Rotarex device (BD) for patients with femoropopliteal disease.
Dr. Michael Lichtenberg...
12/11/2023
Vascular Disease Management

Stay in the Know

Vascular Disease Management Newsletter

News

Abdominal Aortic Aneurysm
Data Presented on Two-Year Proximal Neck Dynamics From First-in-Human Study of Abdominal Aortic Aneurysm Treatment
06/26/2026
Tempe, AZ – June 25, 2026 – Nectero Therapeutics announced today a first-in-human (FIH) multicenter study evaluated treatment of small- to medium-sized abdominal aortic aneurysms (AAA) with pentagalloylglucose (PGG) using its investigational...
Tempe, AZ – June 25, 2026 – Nectero Therapeutics announced today a first-in-human (FIH) multicenter study evaluated treatment of small- to medium-sized abdominal aortic aneurysms (AAA) with pentagalloylglucose (PGG) using its investigational...
Tempe, AZ – June 25, 2026 –...
06/26/2026
Vascular Disease Management
New Guiding Sheath
Volante™ Steerable Guiding Sheath Now Available in US
06/23/2026
Key Highlights  The Volante Steerable Guiding Sheath is designed to facilitate intracardiac, renal and peripheral placement of diagnostic and therapeutic devices.  With five different lengths and six different French sizes,...
Key Highlights  The Volante Steerable Guiding Sheath is designed to facilitate intracardiac, renal and peripheral placement of diagnostic and therapeutic devices.  With five different lengths and six different French sizes,...
Key Highlights  The...
06/23/2026
Vascular Disease Management
Clinical Trials
SYMPHONY-PE Trial Post-Hoc Analysis Suggests Early Thrombectomy May Improve Key Measures of Heart Recovery in Intermediate-Risk Pulmonary Embolism
06/18/2026
Treating patients within 12 hours of diagnosis may be associated with greater improvement in acute hemodynamic and right ventricle measures compared to treatment after 12 hours, with similar safety outcomes between groups.
Treating patients within 12 hours of diagnosis may be associated with greater improvement in acute hemodynamic and right ventricle measures compared to treatment after 12 hours, with similar safety outcomes between groups.
Treating patients within 12...
06/18/2026
Cath Lab Digest
Team Communication
IB Nimble 2 Adds In-App DICOM Viewing for Real-Time Multidisciplinary Collaboration
06/17/2026
The most notable enhancement is the ability to view medical images directly within the app. This long-awaited feature enables care teams to review imaging in real time.
The most notable enhancement is the ability to view medical images directly within the app. This long-awaited feature enables care teams to review imaging in real time.
The most notable enhancement is...
06/17/2026
Cath Lab Digest
CE Mark
Penumbra Expands CAVT for Stroke to Europe with CE Mark for THUNDERBOLT
06/16/2026
The THUNDERBOLT™ Computer Assisted Vacuum Thrombectomy (CAVT™) technology introduces modulated aspiration for acute ischemic stroke for the first time, enabling more rapid, complete clot removal.
The THUNDERBOLT™ Computer Assisted Vacuum Thrombectomy (CAVT™) technology introduces modulated aspiration for acute ischemic stroke for the first time, enabling more rapid, complete clot removal.
The THUNDERBOLT™ Computer...
06/16/2026
Cath Lab Digest
FDA Clearance
Penumbra’s THUNDERBOLT Receives FDA Clearance - Bringing Computer Assisted Vacuum Thrombectomy Technology to Stroke
06/15/2026
Powered by the Penumbra ENGINE™, THUNDERBOLT introduces modulated aspiration to Penumbra’s neuro thrombectomy portfolio, offering advanced CAVT technology designed to detect, fatigue, and completely ingest clot at the site of the occlusion. 
Powered by the Penumbra ENGINE™, THUNDERBOLT introduces modulated aspiration to Penumbra’s neuro thrombectomy portfolio, offering advanced CAVT technology designed to detect, fatigue, and completely ingest clot at the site of the occlusion. 
Powered by the Penumbra ENGINE™,...
06/15/2026
Cath Lab Digest
Veterans With PAD
Department of Veteran Affairs Referrals for Peripheral Artery Disease Nearly Triples Over the Past Five Years
06/15/2026
More than 180,000 veterans receive care for PAD in Department of Veterans Affairs hospitals.
More than 180,000 veterans receive care for PAD in Department of Veterans Affairs hospitals.
More than 180,000 veterans...
06/15/2026
Cath Lab Digest
Thrombolex, Inc.
Thrombolex, Inc. Names Michael Tutera Chief Executive Officer
06/12/2026
New Britain, PA, June 15, 2026 – Thrombolex, Inc., a commercial-stage medical device company advancing a differentiated pharmaco-mechanical lysis (PML) platform for the treatment of pulmonary embolism (PE) and other thromboembolic diseases,...
New Britain, PA, June 15, 2026 – Thrombolex, Inc., a commercial-stage medical device company advancing a differentiated pharmaco-mechanical lysis (PML) platform for the treatment of pulmonary embolism (PE) and other thromboembolic diseases,...
New Britain, PA, June 15, 2026 –...
06/12/2026
Vascular Disease Management
PAD Guidelines
VAM26: Complete Adherence to Guideline-Directed Care Associated with Decreased Serious Limb Complications at Two Years
06/10/2026
“Our study was designed to establish the evidence of a comprehensive multidisciplinary approach before considering surgical intervention,” said Dr. Richard Shi, vascular surgery resident at the Medical University of South Carolina. “Too...
“Our study was designed to establish the evidence of a comprehensive multidisciplinary approach before considering surgical intervention,” said Dr. Richard Shi, vascular surgery resident at the Medical University of South Carolina. “Too...
“Our study was designed to...
06/10/2026
Cath Lab Digest
Thrombectomy
First-in-Human Clinical Success with Novel Mechanical Thrombectomy System
06/09/2026
"The V-PULSE system removed significant clot burden and provided immediate visual confirmation of thrombus capture through its integrated filtration technology," said Makmood Razavi, MD.
"The V-PULSE system removed significant clot burden and provided immediate visual confirmation of thrombus capture through its integrated filtration technology," said Makmood Razavi, MD.
"The V-PULSE system removed...
06/09/2026
Vascular Disease Management

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use